ConvaTec Group PLC Annual General Meeting Update (6035I)
02 Aprile 2020 - 1:45PM
UK Regulatory
TIDMCTEC
RNS Number : 6035I
ConvaTec Group PLC
02 April 2020
ConvaTec Group Plc
Statement regarding the ConvaTec Annual General Meeting due
to
COVID-19
READING, UNITED KINGDOM (2 April 2020)
In light of the rapidly evolving events of the COVID-19
outbreak, the Directors of ConvaTec Group Plc (the "Company") have
made the decision to hold the Company's 2020 Annual General Meeting
("AGM" or "Meeting") in the form of a hybrid meeting, which will
allow shareholders to attend and participate in the Meeting
electronically.
In furtherance of this decision, the AGM will no longer be held
at The Roseate Reading Hotel, but will instead take place on 7 May
2020 at 11am, at the Company's registered office, 3 Forbury Place,
23 Forbury Road, Reading, RG1 3JH. We ask that shareholders do not
attend the meeting in person, but instead join the Meeting
remotely.
Information and instructions, detailing how shareholders may
attend and participate in the Meeting electronically can be found
on our website at, www.convatecgroup.com/investors , where we will
also provide shareholders with further information in relation to
the AGM, should it be necessary to do so.
A printed copy of the aforementioned information and
instructions will be posted to shareholders who elect to receive
hard copies of documentation.
The well-being of our shareholders is vitally important to us
and we recommend that shareholders adhere to the current
instructions from the Government and Public Health England's advice
to stay at home. We encourage shareholders to vote on the
resolutions proposed within the Notice of Meeting by completion of
the Form of Proxy or by electronic means, further details of which
can be found in the Notice of Meeting. Please note the deadline for
submitting proxies will be 11am on Tuesday 5 May 2020.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Haynes +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
UPDFZGGDMZZGGZM
(END) Dow Jones Newswires
April 02, 2020 07:45 ET (11:45 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Apr 2023 a Apr 2024